Phase 2 Study To Evaluate Safety And Efficacy Of Investigational Drug - PF04937319 In Patients With Type 2 Diabetes

PHASE2CompletedINTERVENTIONAL
Enrollment

345

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

January 31, 2013

Study Completion Date

January 31, 2013

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

Placebo

double-dummy placebo tablets administered once-daily for 84-days

DRUG

PF-04937319 - 3mg

PF-04937319 3mg administered as tablets once-daily for 84-days

DRUG

PF-04937319 - 20mg

PF-04937319 20mg administered as tablets once-daily for 84-days

DRUG

PF-04937319 - 50mg

PF-04937319 50mg administered as tablets once-daily for 84-days

DRUG

PF-04937319 - 100mg

PF-04937319 100mg administered as tablets once-daily for 84-days

DRUG

Sitagliptin - 100mg

Sitagliptin 100mg administered as tablets once-daily for 84-days

Trial Locations (63)

220

Far Eastern Memorial Hospital, Division of Endocrinology and Metabolism, New Taipei City

500

Changhua Christian Hospital, Changhua

710

Chi Mei Medical Center, Tainan City

1022

AA Mahomed Medical Centre, Moloto South

1036

Qualiclinic Kft., Budapest

1605

The Medical City, Pasig

1685

Midrand Medical Centre, Midrand

1810

Institute for Studies on Diabetes Foundation Inc., Marikina City

1829

Dr DR Lakha's Practice, Johannesburg

2090

Dr Bhana, Waverley

4032

Debreceni Egyetem Orvos- es Egeszsegtudomanyi Centrum, Debrecen

4043

Kenezy Korhaz Rendelointezet Egeszsegugyi Nonprofit Kft., Debrecen

4090

Polgar es Tersege Egeszsegugyi Kozpont Nonprofit Zrt., Polgár

4091

Randles Road Medical Centre, Durban

5600

Dr. Rethy Pal Korhaz-Rendelointezet, Békéscsaba

6000

Vicente Sotto Memorial Medical Center, Cebu City

6720

Szegedi Tudomanyegyetem Szent-Gyorgyi Albert Klinikai Kozpont, Szeged

8230

DRC Kft., Balatonfüred

8301

Dr JH Mynhardt, Kimberley

8900

Zala Megyei Korhaz, Zalaegerszeg

9023

Petz Aladar Megyei Oktato Korhaz, Győr

9301

Bloemfontein Medi-Clinic, Bloemfontein

14609

Rochester Clinical Research, Inc., Rochester

29407

Medical Research South, LLC, Charleston

Newton Family Medicine, Charleston

30094

Rockdale Medical Research Associates, Conyers

33135

Swiss Medical Research, Miami

34420

The Family Doctors of Belleview, Belleview

34471

Renstar Medical Research, Ocala

40353

Central Kentucky Research Associates, Inc., Mount Sterling

Mount Sterling Clinic, Mount Sterling

40705

Taichung Veterans General Hospital, Division of Metabolism and Endocrinology, Taichung

45429

PriMed Clinical Research, Kettering

PriMed Physicians, Kettering

58103

Lillestol Research, LLC, Fargo

73112

Lynn Health Science Institute, Oklahoma City

75024

Plano Primary Care Clinic, Plano

77081

Texas Center for Drug Development, Inc., Houston

77375

Martin Diagnostic Clinic, Tomball

77479

Pioneer Research Solutions, Inc., Sugar Land

78756

Austin Center for Clinical Research, Austin

83646

Solaris Clinical Research, Meridian

89144

The Office of Dr. Matthew S. Barton, MD, Las Vegas

90057

National Research Institute, Los Angeles

91978

Encompass Clinical Research, Spring Valley

92801

Anaheim Clinical Trials, Anaheim

302001

S.R. Kalla Memorial Gastro and General Hospital, Jaipur

400006

Spitalul Clinic Judetean de Urgenta Cluj-Napoca, Cluj-Napoca

411001

Jehangir Clinical Development Centre Pvt. Ltd., Pune

07652

TKL Research, Inc., Paramus

400 007

Bhatia Hospital, Mumbai

400 012

Seth G S Medical College & KEM Hospital, Dept of Endocrinology,, Mumbai

011234

Institutul National de Diabet, Nutritie si Boli Metabolice Prof. Dr. N. Paulescu, Bucharest

020475

Institutul National de Diabet, Nutritie si Boli Metabolice Prof. Dr. N. Paulescu, Bucharest

831 01

Metabolicke centrum MUDr. Katariny Raslovej, s.r.o., Bratislava

851 01

Medispektrum Plus, s.r.o., Bratislava

984 01

IN-DIA, s.r.o., Lučenec

949 01

MUDr. Zuzana Ochodnicka, Interna diabetologicka ambulancia, s.r.o., Nitra

915 01

NOEMIS, s.r.o., Nové Mesto nad Váhom

080 01

DIABETOL, s.r.o., Prešov

075 01

Areteus, s.r.o., Trebišov

911 01

Diabetes centrum, s.r.o., Trenčín

0083

Medi-Clinic Heart Hospital, Pretoria

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT01475461 - Phase 2 Study To Evaluate Safety And Efficacy Of Investigational Drug - PF04937319 In Patients With Type 2 Diabetes | Biotech Hunter | Biotech Hunter